GLUFAST is indicated for improvement in postprandial plasma glucose transition in patients with type 2 diabetes mellitus who experience inadequate response to any of the following treatments: Dietary treatment and exercise therapy alone; Use of α-glucosidase inhibitors, in addition to diet and physical exercise.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
